Hearing impairment in middle-aged patients with diabetes

Most studies focus on elderly patients with type 2 diabetes mellitus (T2DM). There is little known about the hearing of middle-aged subjects with T2DM. The objective of this study is to evaluate hearing impairment in patients aged 40–50 years with T2DM using pure-tone audiometry and high-frequency a...

Full description

Bibliographic Details
Main Authors: Fazıl Emre Ozkurt, Mehmet Akdag, Mazhar Muslum Tuna, Beyhan Yilmaz, Engin Sengul, Mehmet Sinan Dal
Format: Article
Language:English
Published: Taylor & Francis Group 2016-07-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Online Access:http://dx.doi.org/10.1080/13102818.2016.1170631
_version_ 1818555990619979776
author Fazıl Emre Ozkurt
Mehmet Akdag
Mazhar Muslum Tuna
Beyhan Yilmaz
Engin Sengul
Mehmet Sinan Dal
author_facet Fazıl Emre Ozkurt
Mehmet Akdag
Mazhar Muslum Tuna
Beyhan Yilmaz
Engin Sengul
Mehmet Sinan Dal
author_sort Fazıl Emre Ozkurt
collection DOAJ
description Most studies focus on elderly patients with type 2 diabetes mellitus (T2DM). There is little known about the hearing of middle-aged subjects with T2DM. The objective of this study is to evaluate hearing impairment in patients aged 40–50 years with T2DM using pure-tone audiometry and high-frequency audiometry. Forty patients with T2DM (19 males, 21 females) and 40 (20 males, 20 females) age and sex similar controls were included. All subjects completed clinical, laboratory and auditory assessments. Pure-tone audiometry auditory tests and high-frequency audiometry tests were performed in a soundproof room for each ear using the AC-40 audiometer from Interacoustics with a special earphone appropriate for high frequency. In the T2DM group, the duration of T2DM was between 5 and 15 years (7.7 ± 2.4 years). At all frequencies, the thresholds of the T2DM group were higher than the control group for both right and left ears and also significant. However, the thresholds at standard frequencies (125–8000 Hz) for both group's average were lower than 20 dB-HL and were considered to be normal, and at high frequencies (9000–16,000 Hz) the T2DM group's average thresholds were higher than 20 dB-HL and considered to be a hearing loss. A Spearman's correlation test was done between the duration of T2DM and hearing thresholds. There was a mild correlation between the duration of T2DM and hearing thresholds in all frequencies. In conclusion, patients with type 2 diabetes have a high prevalence of subclinical sensorineural hearing loss. High-frequency audiometry can be used in hearing assessment screening of diabetic patients.
first_indexed 2024-12-13T23:41:41Z
format Article
id doaj.art-46b1a025f98f4a7b8d1bfe4bc695ca74
institution Directory Open Access Journal
issn 1310-2818
1314-3530
language English
last_indexed 2024-12-13T23:41:41Z
publishDate 2016-07-01
publisher Taylor & Francis Group
record_format Article
series Biotechnology & Biotechnological Equipment
spelling doaj.art-46b1a025f98f4a7b8d1bfe4bc695ca742022-12-21T23:27:08ZengTaylor & Francis GroupBiotechnology & Biotechnological Equipment1310-28181314-35302016-07-0130473774110.1080/13102818.2016.11706311170631Hearing impairment in middle-aged patients with diabetesFazıl Emre Ozkurt0Mehmet Akdag1Mazhar Muslum Tuna2Beyhan Yilmaz3Engin Sengul4Mehmet Sinan Dal5Faculty of Medicine, Dicle UniversityFaculty of Medicine, Dicle UniversityFaculty of Medicine, Dicle UniversityFaculty of Medicine, Dicle UniversityFaculty of Medicine, Dicle UniversityFaculty of Medicine, Dicle UniversityMost studies focus on elderly patients with type 2 diabetes mellitus (T2DM). There is little known about the hearing of middle-aged subjects with T2DM. The objective of this study is to evaluate hearing impairment in patients aged 40–50 years with T2DM using pure-tone audiometry and high-frequency audiometry. Forty patients with T2DM (19 males, 21 females) and 40 (20 males, 20 females) age and sex similar controls were included. All subjects completed clinical, laboratory and auditory assessments. Pure-tone audiometry auditory tests and high-frequency audiometry tests were performed in a soundproof room for each ear using the AC-40 audiometer from Interacoustics with a special earphone appropriate for high frequency. In the T2DM group, the duration of T2DM was between 5 and 15 years (7.7 ± 2.4 years). At all frequencies, the thresholds of the T2DM group were higher than the control group for both right and left ears and also significant. However, the thresholds at standard frequencies (125–8000 Hz) for both group's average were lower than 20 dB-HL and were considered to be normal, and at high frequencies (9000–16,000 Hz) the T2DM group's average thresholds were higher than 20 dB-HL and considered to be a hearing loss. A Spearman's correlation test was done between the duration of T2DM and hearing thresholds. There was a mild correlation between the duration of T2DM and hearing thresholds in all frequencies. In conclusion, patients with type 2 diabetes have a high prevalence of subclinical sensorineural hearing loss. High-frequency audiometry can be used in hearing assessment screening of diabetic patients.http://dx.doi.org/10.1080/13102818.2016.1170631Type 2 diabeteshearing impairmentpure-tone audiometrysensorineural hearing loss
spellingShingle Fazıl Emre Ozkurt
Mehmet Akdag
Mazhar Muslum Tuna
Beyhan Yilmaz
Engin Sengul
Mehmet Sinan Dal
Hearing impairment in middle-aged patients with diabetes
Biotechnology & Biotechnological Equipment
Type 2 diabetes
hearing impairment
pure-tone audiometry
sensorineural hearing loss
title Hearing impairment in middle-aged patients with diabetes
title_full Hearing impairment in middle-aged patients with diabetes
title_fullStr Hearing impairment in middle-aged patients with diabetes
title_full_unstemmed Hearing impairment in middle-aged patients with diabetes
title_short Hearing impairment in middle-aged patients with diabetes
title_sort hearing impairment in middle aged patients with diabetes
topic Type 2 diabetes
hearing impairment
pure-tone audiometry
sensorineural hearing loss
url http://dx.doi.org/10.1080/13102818.2016.1170631
work_keys_str_mv AT fazılemreozkurt hearingimpairmentinmiddleagedpatientswithdiabetes
AT mehmetakdag hearingimpairmentinmiddleagedpatientswithdiabetes
AT mazharmuslumtuna hearingimpairmentinmiddleagedpatientswithdiabetes
AT beyhanyilmaz hearingimpairmentinmiddleagedpatientswithdiabetes
AT enginsengul hearingimpairmentinmiddleagedpatientswithdiabetes
AT mehmetsinandal hearingimpairmentinmiddleagedpatientswithdiabetes